Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end ...

Piramal Pharma Limited is a global pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. It operates approximately ...

Piramal Enterprises said it has solid grounds to challenge the "unjustified" demand. The company sold its pharmaceutical business and other related units to Piramal Pharma for 44.87 billion rupees in ...

Piramal’s issues didn't stop there, with the FDA also noting that the company’s investigations into active pharmaceutical ingredient (API) batch deviations lacked adequate follow-up.

BrePco Biopharma Limited today announced that the UK Medicines and Healthcare products Regulatory Agency issued a grant of a ...

With a promising outlook for PTC India and Piramal Pharma, Bajaj Broking identifies key stock picks poised for over 15% ...

India's Piramal Enterprises hit with nearly $172 million tax bill for pharma deal India's Piramal Enterprises said in an exchange filing on Friday that it had received a tax demand of 15.02 ...

Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...